4//SEC Filing
Omega Fund IV GP, L.P. 4
Accession 0000899243-21-048798
CIK 0001811063other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 5:13 PM ET
Size
8.7 KB
Accession
0000899243-21-048798
Insider Transaction Report
Form 4
Omega Fund V, L.P.
10% Owner
Transactions
- Sale
Common Stock
2021-12-15$10.07/sh−500,000$5,035,000→ 22,957,340 total
Omega Fund IV GP, L.P.
10% Owner
Transactions
- Sale
Common Stock
2021-12-15$10.07/sh−500,000$5,035,000→ 22,957,340 total
Omega Fund V GP Manager, Ltd.
10% Owner
Transactions
- Sale
Common Stock
2021-12-15$10.07/sh−500,000$5,035,000→ 22,957,340 total
Footnotes (2)
- [F1]The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]The reported securities are held directly by Omega Fund V, L.P. ("Omega V"). The reported securities may be deemed to be beneficially owned by each of Omega Fund V GP, L.P. ("Omega V GP"), as the general partner of Omega V, and Omega Fund V GP Manager, Ltd. ("Omega V GP Manager"), as the general partner of Omega V GP. Otello Stampacchia, Claudio Nessi and Anne-Mari Paster are all the shareholders and directors of Omega V GP Manager and have shared voting and investment power over the shares held by Omega V. Each of Omega V GP, Omega Fund V GP Manager and the Omega Directors disclaims beneficial ownership of the securities reported herein, except to the extent of its or their pecuniary interest therein, if any.
Documents
Issuer
Nuvation Bio Inc.
CIK 0001811063
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001528383
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 5:13 PM ET
- Size
- 8.7 KB